Status:
WITHDRAWN
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome
Lead Sponsor:
Lahey Clinic
Conditions:
Sleep Apnea, Obstructive
Sleep Apnea
Eligibility:
MALE
18-70 years
Brief Summary
Obstructive Sleep Apnea Syndrome (OSAS)is a common disease and is suspected to be associated with sexual dysfunction. Our purpose is to sudy the effect of CPAP (Continuous Positive Airway Pressure) tr...
Detailed Description
Obstructive Sleep Apnea Syndrome(OSAS) is a highly prevalent disease in the population, affecting at least 4% of males and to a lesser extent females, yet it is currently under diagnosed. OSAS is asso...
Eligibility Criteria
Inclusion
- Adult males ages 18-70 with newly diagnosed OSAS documented by all-night polysomnography (PSG)
Exclusion
- Currently on testosterone replacement therapy
- Prior known cause of erectile dysfunction
- Patients with prior treatment of erectile dysfunction
- Co-morbid conditions like diabetes, hypertension, as well as patient medications, will be recorded, and will not be part of the exclusion criteria
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00832065
Start Date
January 1 2009
End Date
August 1 2016
Last Update
August 24 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lahey Clinic, Inc.
Burlington, Massachusetts, United States, 01805
2
Lahey Clinic Northshore
Peabody, Massachusetts, United States, 01960